Matthieu Mahévas

3.3k total citations · 1 hit paper
66 papers, 1.6k citations indexed

About

Matthieu Mahévas is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Matthieu Mahévas has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 22 papers in Genetics and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Matthieu Mahévas's work include Platelet Disorders and Treatments (42 papers), Blood groups and transfusion (28 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Matthieu Mahévas is often cited by papers focused on Platelet Disorders and Treatments (42 papers), Blood groups and transfusion (28 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Matthieu Mahévas collaborates with scholars based in France, United States and Italy. Matthieu Mahévas's co-authors include Bertrand Godeau, Sylvain Audia, Marc Michel, Bernard Bonnotte, M. Samson, Philippe Bierling, Nicolas Limal, Mehdi Khellaf, Laetitia Languille and Françoise Roudot‐Thoraval and has published in prestigious journals such as Blood, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Matthieu Mahévas

59 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

2022 99 citations Léa Hoisnard, Bénédicte Lebrun‐Vignes et al. Scientific Reports profile →

Peers

Countries citing papers authored by Matthieu Mahévas

Since Specialization

Citations

This map shows the geographic impact of Matthieu Mahévas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Mahévas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Mahévas more than expected).

Fields of papers citing papers by Matthieu Mahévas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Mahévas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Mahévas. The network helps show where Matthieu Mahévas may publish in the future.

Co-authorship network of co-authors of Matthieu Mahévas

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Mahévas. A scholar is included among the top collaborators of Matthieu Mahévas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Mahévas. Matthieu Mahévas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia? 2024 ·British Journal of Haematology ·Sydney Dubois, Richard Layese, Nicolas Limal, Laetitia Languille, (unknown), Matthieu Mahévas, Marc Michel, Étienne Audureau, Bertrand Godeau	0
2	Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry 2024 ·British Journal of Haematology ·Guillaume Moulis, (unknown), (unknown), Matthieu Mahévas, Jean‐François Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikaël Ebbo, Louis Terriou, Jean‐Christophe Lega, Pierre‐Yves Jeandel, (unknown), (unknown), Ahmed Daak, Hikaru Okada, Bernard Bonnotte, Marc Michel, Maryse Lapeyre‐Mestre, Bertrand Godeau, (unknown)	4
3	B cells and antibodies in refractory immune thrombocytopenia 2023 ·British Journal of Haematology ·Anaïs Roeser, Alan H. Lazarus, Matthieu Mahévas	15
4	FRI531 IgG4 Related Mass -forming Thyroid Disease: Two Case Reports 2023 ·Journal of the Endocrine Society ·(unknown), Céline Droumaguet, (unknown), J. Tran-Van-Nhieu, Émilie Béquignon, Pascal Desgranges, Nicolas Limal, Matthieu Mahévas, Bertrand Godeau	0
5	Older Adults and Immune Thrombocytopenia: Considerations for the Clinician 2023 ·Clinical Interventions in Aging ·Étienne Crickx, Matthieu Mahévas, Marc Michel, Bertrand Godeau	8
6	Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database breakdown → 2022 ·Scientific Reports ·Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, (unknown), Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian	99
7	Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia 2021 ·Haematologica ·Étienne Crickx, Sylvain Audia, A. Robbins, David Boutboul, Thibault Comont, Morgane Cheminant, Éric Oksenhendler, Bertrand Godeau, Marc Michel, Matthieu Mahévas	29
8	Prise en charge du purpura thrombopénique immunologique multiréfractaire 2020 ·La Revue de Médecine Interne ·Matthieu Mahévas, Sylvain Audia, Jean‐François Viallard	1
9	Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES 2019 ·Blood ·(unknown), France Pirenne, Marc Michel, Armand Mekontso Dessap, Matthieu Mahévas, Constance Guillaud, Keyvan Razazi, Eléna Foïs, Frédéric Galactéros, Pablo Bartolucci, Anoosha Habibi	6
10	Monoclonal Gammopathy, Arthralgias, and Recurrent Fever Syndrome: A New Autoinflammatory Syndrome? 2019 ·The Journal of Rheumatology ·(unknown), Alexis Talbot, Camille Louvrier, (unknown), Matthieu Mahévas, David Boutboul, Serge Amselem, Irina Giurgea, Gilles Grateau, Sophie Georgin‐Lavialle	4
11	Pathogenesis of immune thrombocytopenia 2017 ·Autoimmunity Reviews ·Sylvain Audia, Matthieu Mahévas, M. Samson, Bertrand Godeau, Bernard Bonnotte	254
12	Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort 2016 ·Digestive and Liver Disease ·Mathieu Uzzan, Lionel Galicier, Jean‐Marc Gornet, Éric Oksenhendler, Claire Fieschi, Matthieu Allez, Yoram Bouhnik, Julien Kirchgesner, David Boutboul, Xavier Tréton, Laurence Gérard, Matthieu Mahévas, Jacques Cosnes, Aurélien Amiot	27
13	Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis 2015 ·Autoimmunity Reviews ·Guillaume Moulis, Alexandra Audemard‐Verger, Laurent Arnaud, (unknown), François Montastruc, Amelia Maria Găman, Elisabet Svenungsson, Marco Ruggeri, Matthieu Mahévas, Mathieu Gerfaud‐Valentin, Andrés Brainsky, Marc Michel, Bertrand Godeau, Maryse Lapeyre‐Mestre, L. Sailler	54
14	Complications de la splénectomie au cours du purpura thrombopénique immunologique. Revue de la littérature et mesures de prévention 2013 ·La Revue de Médecine Interne ·Matthieu Mahévas, Hélène Coignard-Biehler, Marc Michel, Olivier Lortholary, Bertrand Godeau	1
15	Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia 2012 ·Blood ·Vivek Patel, Matthieu Mahévas, Soo Yong Lee, Roberto Stasi, Susanna Cunningham–Rundles, Bertrand Godeau, Julie Kanter, Ellis J. Neufeld, Tillmann Taube, Ugo Ramenghi, Shalini Shenoy, Mary J. Ward, Nino Mihatov, (unknown), Philippe Bierling, Martin Lesser, Nichola Cooper, James B. Bussel	243
16	Association of Sarcoidosis and Immune Thrombocytopenia 2011 ·Medicine ·Matthieu Mahévas, Laurent Chiche, Y. Uzunhan, M. Khellaf, (unknown), G. Le Guenno, (unknown), (unknown), Olivier Lidove, David Boutboul, Geneviève Dion, Jean-Pierre Ducroix, T. Papo, Yves Pachéco, N. Schleinitz, Marc Michel, Bertrand Godeau, Dominique Valeyre	18
17	Scalp necrosis in giant cell arteritis. 2007 ·PubMed ·Matthieu Mahévas, Victoire de Lastours, Guillaume Bussone, Mehdi Khellaf	1
18	Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine 2007 ·Haematologica ·Matthieu Mahévas, Sylvain Audia, Victoire de Lastours, Marc Michel, (unknown), Bertrand Godeau	14
19	Intensification thérapeutique dans les maladies auto-immunes 2007 ·La Revue de Médecine Interne ·Matthieu Mahévas, (unknown), (unknown), (unknown), Bruno Royer, (unknown), Gandhi Damaj, P. Duhaut, (unknown), J.P. Ducroix, Jean Pierre Marolleau	1
20	Spectre étiologique des hyperferritinémies 2005 ·La Revue de Médecine Interne ·(unknown), (unknown), Matthieu Mahévas, P. Duhaut, А. Смаил, V. Salle, R. Cévallos, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact